Cytodyn is Pharmaceuticals in United States that focus on potential commercialization business. Founded in 2002. They cover business area such as CytoDyn Inc, potential commercialization, humanize monoclonal, Human Immunodeficiency Virus (HIV) infection, PRO, HIV therapy, entry inhibitor, certain cell, opportunity, clinical application, ) receptor, HIV-relate treatment, inflammatory condition, autoimmune disease, cancer.
2002
( 24 years old in 2026 )
Potential Commercialization
-
1111 Main Street
Suite 660
Vancouver, WA 98660
United States
Private
CytoDyn Incpotential commercializationhumanize monoclonalHuman Immunodeficiency Virus (HIV) infectionPROHIV therapyentry inhibitorcertain cellopportunityclinical application) receptorHIV-relate treatmentinflammatory conditionautoimmune diseasecancer
* We use standard office opening hours in near Cytodyn's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cytodyn is Pharmaceuticals business from United States that founded in 2002 (24 years old in 2026), Cytodyn business is focusing on Potential Commercialization.
Cytodyn headquarter office and corporate office address is located in 1111 Main Street Suite 660 Vancouver, WA 98660 United States.
Cytodyn was founded in United States.
In 2026, Cytodyn is currently focus on potential commercialization sector.
Above is snippet of Google Trends for "potential commercialization" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cytodyn, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.